Kai Lv

1.9k total citations
88 papers, 1.5k citations indexed

About

Kai Lv is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Kai Lv has authored 88 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 29 papers in Infectious Diseases and 24 papers in Organic Chemistry. Recurrent topics in Kai Lv's work include Cancer therapeutics and mechanisms (30 papers), Tuberculosis Research and Epidemiology (13 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (13 papers). Kai Lv is often cited by papers focused on Cancer therapeutics and mechanisms (30 papers), Tuberculosis Research and Epidemiology (13 papers) and Phenothiazines and Benzothiazines Synthesis and Activities (13 papers). Kai Lv collaborates with scholars based in China, United States and United Kingdom. Kai Lv's co-authors include Mingliang Liu, Huiyuan Guo, Yu Lu, Apeng Wang, Lian‐Shun Feng, Yun Chai, Dong Ma, Guowei Li, Bo Wang and Xiaowei Liu and has published in prestigious journals such as Advanced Functional Materials, The Science of The Total Environment and Chemical Engineering Journal.

In The Last Decade

Kai Lv

83 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Lv China 24 701 604 357 160 149 88 1.5k
William R. Wolter United States 21 502 0.7× 381 0.6× 180 0.5× 62 0.4× 134 0.9× 47 1.5k
Rainer Riedl Switzerland 18 578 0.8× 255 0.4× 93 0.3× 66 0.4× 118 0.8× 49 1.2k
Rohan Dhiman India 25 602 0.9× 149 0.2× 441 1.2× 354 2.2× 66 0.4× 74 2.1k
Angela Arciello Italy 23 1.1k 1.5× 143 0.2× 99 0.3× 44 0.3× 57 0.4× 72 1.8k
Haruko Takahashi Japan 25 966 1.4× 691 1.1× 60 0.2× 120 0.8× 187 1.3× 66 2.2k
Jeffrey M. McGuire United States 10 490 0.7× 272 0.5× 55 0.2× 64 0.4× 132 0.9× 23 1.3k
Shan Li China 23 462 0.7× 799 1.3× 479 1.3× 153 1.0× 36 0.2× 115 2.0k
Manuela Benvenuti Italy 18 393 0.6× 103 0.2× 130 0.4× 215 1.3× 413 2.8× 37 1.3k
Tea Pavkov‐Keller Austria 24 969 1.4× 169 0.3× 47 0.1× 38 0.2× 73 0.5× 72 1.6k
Neha Sharma India 14 240 0.3× 109 0.2× 198 0.6× 166 1.0× 27 0.2× 41 947

Countries citing papers authored by Kai Lv

Since Specialization
Citations

This map shows the geographic impact of Kai Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Lv more than expected).

Fields of papers citing papers by Kai Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Lv. The network helps show where Kai Lv may publish in the future.

Co-authorship network of co-authors of Kai Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Lv. A scholar is included among the top collaborators of Kai Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Lv. Kai Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Jiang, Bin, Jizhou Wu, Huijuan Song, et al.. (2025). Identification of selenium-containing benzamides as potent microtubule-targeting antitumor agents. Bioorganic Chemistry. 159. 108355–108355. 2 indexed citations
3.
Zhao, Ziyi, Yue Wang, Yucheng Wang, et al.. (2025). Optimizing efficacy: Hyaluronic acid liposomes encapsulating minoxidil for enhanced transdermal delivery and treatment of androgenetic alopecia. Colloids and Surfaces B Biointerfaces. 255. 114956–114956.
4.
Zhou, Shihao, Chengguang Wu, Pengfei Shen, et al.. (2024). Tumor microenvironment-responsive multifunctional nanoplatform with selective toxicity for MRI-guided photothermal/photodynamic/nitric oxide combined cancer therapy. Chemical Engineering Journal. 481. 148618–148618. 26 indexed citations
5.
Fan, Shiyong, Qilong Li, Lianqi Liu, et al.. (2024). Novel antibody-antibiotic conjugate using KRM-1657 as payload eliminates intracellular MRSA in vitro and in vivo. Bioorganic Chemistry. 150. 107532–107532. 1 indexed citations
6.
Wu, Jizhou, Na Du, Chao Ma, et al.. (2024). Design, synthesis and antimycobacterial activity of novel benzothiazinones with improved water solubility. European Journal of Medicinal Chemistry. 279. 116829–116829.
7.
8.
Song, Huijuan, et al.. (2024). The STAT3 inhibitor B9 alleviates lipopolysaccharide-induced acute lung injury through its anti-inflammatory effects. International Immunopharmacology. 135. 112221–112221. 2 indexed citations
9.
10.
Wu, Jian, Shihao Zhou, Kai Lv, et al.. (2024). Rapidly photocrosslinkable modified PF‐127 hydrogels for treatment of hemorrhage. Journal of Applied Polymer Science. 141(34). 1 indexed citations
11.
Song, Huijuan, Shangze Yang, Shuo Wu, et al.. (2024). Identification of dihydroquinolizinone derivatives with nitrogen heterocycle moieties as new anti-HBV agents. European Journal of Medicinal Chemistry. 268. 116280–116280. 1 indexed citations
12.
Chen, Xingjuan, Yunzheng Yan, Huijuan Song, et al.. (2023). Investigation of novel 5ʹ-amino adenosine derivatives with potential anti-Zika virus activity. European Journal of Medicinal Chemistry. 261. 115852–115852. 4 indexed citations
13.
Wang, Apeng, Na Du, Huijuan Song, et al.. (2023). Design, synthesis and antitubercular activity of novel N-(amino)piperazinyl benzothiazinones with improved safety. European Journal of Medicinal Chemistry. 258. 115545–115545. 6 indexed citations
14.
Lv, Kai, Guowei Li, Ziheng Chen, et al.. (2023). Bacteria‐Targeted Combined with Photothermal/NO Nanoparticles for the Treatment and Diagnosis of MRSA Infection In Vivo. Advanced Healthcare Materials. 12(20). e2300247–e2300247. 34 indexed citations
15.
Li, Lin, Xin Gao, Kai Lv, et al.. (2021). A Novel Nomogram for Survival Prediction of Patients with Spinal Metastasis From Prostate Cancer. Spine. 46(6). E364–E373. 13 indexed citations
16.
Wang, Apeng, Yun Chai, Guimin Xia, et al.. (2021). Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Bioorganic & Medicinal Chemistry. 53. 116529–116529. 10 indexed citations
17.
Lv, Kai, Wenyan Li, Shuo Wu, et al.. (2020). Amino acid prodrugs of NVR3-778: Design, synthesis and anti-HBV activity. Bioorganic & Medicinal Chemistry Letters. 30(9). 127103–127103. 9 indexed citations
18.
Lv, Kai, Shuo Wu, Wenyan Li, et al.. (2019). Design, synthesis and anti-HBV activity of NVR3-778 derivatives. Bioorganic Chemistry. 94. 103363–103363. 17 indexed citations
19.
Wang, Hongjian, Apeng Wang, Jian Gu, et al.. (2018). Synthesis and antitubercular evaluation of reduced lipophilic imidazo[1,2-a]pyridine-3-carboxamide derivatives. European Journal of Medicinal Chemistry. 165. 11–17. 27 indexed citations
20.
Lv, Kai, et al.. (2011). Synthesis and antibacterial activity of naphthyridone derivatives containing mono/difluoro-methyloxime pyrrolidine scaffolds. European Journal of Medicinal Chemistry. 47(1). 619–625. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026